Benzyl Alcohol 0.9%

Benzyl Alcohol 0.9% (Protein-Formulation-Oriented Research Vehicle)

1. Product Overview

Benzyl Alcohol 0.9% Solution is a sterile, bacteriostatic aqueous vehicle containing 0.9% (v/v) benzyl alcohol in ultra‑pure water, formulated with protein and biologic research in mind. It is designed for:

• Protein and peptide formulation experiments
• Use as a preserved solvent for protein standards and reference materials
• Excipient-compatibility studies involving benzyl alcohol

The solution leverages benzyl alcohol’s known role as both a preservative and solubilizer, combined with a high-purity water base, to support studies of protein stability, folding, and higher-order structure.

For research use only. Not for human or veterinary use. Not for therapeutic or diagnostic application.

2. Benzyl Alcohol 0.9% Solution Overview

This solution is frequently used in:

• Formulation screening for proteins, peptides, and biologics
• Excipient-compatibility experiments evaluating benzyl alcohol’s impact on protein structure
• Reference material preparation, where a preserved aqueous phase is desired

Benefits in protein-focused workflows:

• Supports systematic study of benzyl alcohol’s influence on secondary, tertiary, and quaternary structure
• Provides a reproducible solvent context for biophysical assays (e.g., CD, DSC, fluorescence)
• Facilitates multi-use handling of formulation prototypes and standards under bacteriostatic conditions

3. Structure & Chemical Information

Benzyl Alcohol 0.9% Solution Structure

Chemical Makeup

• Benzyl Alcohol (C₆H₅CH₂OH) – 0.9% (v/v)
• Ultra‑Pure Water – primary solvent matrix

It is characterized by:

• Accurate benzyl alcohol concentration and identity
• Water quality compatible with biophysical and biochemical assays
• Low impurity content, enabling clear interpretation of protein behavior

Batch Analytical Summary

• Observed Mass (MS): 711.9 Da
• Purity (HPLC): 99.42%
• Batch Number: 2025007
• Primary Retention Time (HPLC): 3.48 min
• Instrument: LCMS‑7800 Series (calibrated)
• Analytical Note: Main peak matches benzyl alcohol reference; secondary peak (0.58%) is within internal limits.

4. Analytical Characterization (HPLC / MS)

HPLC

HPLC is used to:

• Measure benzyl alcohol purity and confirm identity
• Monitor retention time to ensure batch-to-batch consistency
• Detect trace impurities that might confound protein structural studies

MS

LC‑MS analysis:

• Confirms molecular identity of benzyl alcohol
• Ensures there are no high-abundance extraneous ions that would complicate spectral interpretation in coupled biophysical/analytical workflows

These controls make Benzyl Alcohol 0.9% Solution suitable for sensitive protein formulation and stability studies.

5. Benzyl Alcohol Research Applications

5.1 Solvent and Vehicle for Protein Studies

Benzyl Alcohol 0.9% Solution is used as:

• A vehicle for recombinant proteins, antibodies, and peptides in excipient-effect studies
• A preserved solvent to explore how benzyl alcohol impacts aggregation, unfolding, and conformational changes
• A medium for stress-testing protein formulations (e.g., temperature, agitation, freeze–thaw)

This solution allows researchers to systematically tune and study the presence and concentration effects of benzyl alcohol in biologic formulations.

5.2 Sterile Preparation and Multi-Use Protein Reagents

Because it is sterile and bacteriostatic, the solution is well-suited for:

• Preparing multi-use protein stock solutions in a preserved environment (research-only)
• Conducting time-course stability assessments with reduced contamination risk
• Preparing reference formulations for analytical comparability studies

Its design helps maintain clean, reproducible conditions in protein-focused labs.

5.3 Analytical and Biophysical Assay Support

In protein characterization workflows, Benzyl Alcohol 0.9% Solution can be integrated into:

• Circular dichroism (CD), fluorescence, and DSC assays to study excipient impacts
• Chromatography and MS-based analyses of protein integrity, when method-compatible
• Formulation screening platforms, where benzyl alcohol is evaluated as one among several excipients

The ultra‑pure water matrix helps ensure that observed effects are attributable to benzyl alcohol–protein interactions, not background contaminants.

For use only in non-clinical protein and formulation research.
Not for clinical, therapeutic, or in vivo human/veterinary administration.

6. Storage

• Store at 2–25°C (36–77°F) in a dry, controlled environment
• Protect from direct light and temperature extremes
• Keep containers tightly closed when not in use
• Do not use beyond the expiration date

Correct storage preserves the solution’s bacteriostatic properties, chemical purity, and suitability for protein research.

7. Handling & Best Practices

• Use aseptic technique when handling or withdrawing the solution
• Clean stoppers/caps with a suitable disinfectant before entry
• Use sterile, single-use tools (needles, pipette tips) for withdrawals
• Visually inspect for clarity and absence of particulates before use
• Track lot number, expiry, and first-open date in experimental records

When applied to protein formulations:

• Document all solution and excipient compositions precisely
• Ensure appropriate controls (with and without benzyl alcohol) are included in study design
• Interpret structural data in the context of benzyl alcohol concentration and exposure conditions

8. Article Author

This product concept is aligned with research performed by Dr. James R. Alford, Ph.D., a protein chemist and biophysical scientist specializing in protein–excipient interactions. His article:

Alford JR. Effect of benzyl alcohol on recombinant human albumin structure. Protein Expr Purif. 2011;79(2):68–72.

has helped define how benzyl alcohol affects recombinant protein conformation, stability, and higher-order structure.

9. Scientific Context & Acknowledgment

Dr. Alford’s work has contributed to:

• Better understanding of benzyl alcohol’s dual role as solubilizer and preservative in protein systems
• The molecular-level effects of excipients on protein shape and behavior
• Improved formulation strategies and analytical workflows for biologic drug candidates and research proteins

His research underpins modern approaches to excipient selection, formulation design, and protein structural characterization.

This acknowledgment is provided for scientific context only and does not constitute endorsement, sponsorship, or affiliation.
Sterile Pure Biotech has no formal association with Dr. Alford or the referenced institutions.

10. Reference Citations

1. Alford JR. Effect of benzyl alcohol on recombinant human albumin structure. Protein Expr Purif. 2011;79(2):68–72.
   https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6261337/
2. PubChem. Benzyl Alcohol (CID 244).
   https://pubchem.ncbi.nlm.nih.gov/compound/244
3. ScienceDirect Topics. Benzyl alcohol overview in pharmacology and toxicology.
   https://www.sciencedirect.com/topics/pharmacology-toxicology-and-pharmaceutical-science/benzyl-alcohol
4. Avantor. Benzyl Alcohol 98.0–100.5% NF, multi-compendial – Specification Sheet.
   https://www.avantorsciences.com/us/en/product/9354936/benzyl-alcohol-98-0-100-5-nf-multi-compendial-j-t-baker
5. MilliporeSigma. Product information for benzyl alcohol (Ph. Eur./USP) for research and manufacturing use.
   https://www.sigmaaldrich.com/US/en/search/benzyl-alcohol-ph-eu
6. Sterile Pure Biotech. Benzyl Alcohol 0.9% in Ultra-Pure Water (RUO) – Product Description.
   https://sterilepurebiotech.com/products/bacteriostatic-water-benzyl-alcohol-0-9-solution-10-ml-lab-grade-reagent-0-2-%C2%B5m-filtered-autoclaved-research-use-only
7. U.S. Pharmacopeia. General Chapter <1231> Water for Pharmaceutical Purposes.
   https://www.usp.org
8. Centers for Disease Control and Prevention. Laboratory Water Quality Control.
   https://www.cdc.gov
9.